Safety and Efficacy of the CGuard™ Carotid Stent System in Carotid Artery Stenting
← catalyst calendarSponsored by InspireMD (industry) · NSPR — their whole pipeline →.
Phase
Not applicable
Status
Active, not recruiting
Study type
Interventional
Design
Na · None · Treatment
Enrollment
317actual
Sites
18
Countries
Poland, United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2021-07-01 | actual | When the study began enrolling |
| Primary completion | 2022-07-01 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-10-01 | estimated | The whole study's end, after follow-up |
| First posted | 2021-05-25 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-04-04 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Carotid Artery Stenosis
Intervention
- Device: CGuard Carotid Stent implantation — also filed as Carotid stenting
Primary outcome
what the primary-completion date above is the date OFComposite of DSMI through 30 days or ipsilateral stroke 31 - 365 days post-index procedure
measured From index procedure to 1 year follow up
Permalink · NSPR's whole pipeline · Catalyst calendar · Every registered study · What changed